AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,743,352 | -47.0% | 296,800 | -45.5% | 0.84% | -39.0% |
| Q2 2023 | $39,163,700 | +2.5% | 545,000 | -12.0% | 1.37% | +7.9% |
| Q1 2023 | $38,192,256 | -26.1% | 619,200 | -7.6% | 1.27% | +13.2% |
| Q4 2022 | $51,677,100 | -24.7% | 670,000 | -56.5% | 1.12% | -19.8% |
| Q3 2022 | $68,652,000 | +133.3% | 1,538,600 | +116.4% | 1.40% | +127.7% |
| Q1 2022 | $29,428,000 | +0.5% | 711,000 | -8.3% | 0.61% | -1.3% |
| Q4 2021 | $29,280,000 | +248.2% | 775,000 | +556.8% | 0.62% | +59.2% |
| Q3 2020 | $8,408,000 | -74.8% | 118,000 | -70.9% | 0.39% | -81.7% |
| Q2 2020 | $33,315,000 | +187.4% | 404,900 | +105.5% | 2.14% | +33.3% |
| Q1 2020 | $11,590,000 | – | 197,000 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |